Cargando…
Long-Term Safety and Efficacy of Tacrolimus in Myasthenia Gravis
PURPOSE: Myasthenia gravis (MG) is a lifelong autoimmune disorder that affects neuromuscular transmission. The long-term treatment plan should include immunotherapy. We investigated the long-term safety and efficacy of tacrolimus for the treatment of MG in real-world clinical practice. MATERIALS AND...
Autores principales: | Kim, Yool-hee, Shin, Ha Young, Kim, Seung Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597475/ https://www.ncbi.nlm.nih.gov/pubmed/31250577 http://dx.doi.org/10.3349/ymj.2019.60.7.633 |
Ejemplares similares
-
The Epidemiology of Myasthenia Gravis in Korea
por: Lee, Hyung Seok, et al.
Publicado: (2016) -
Initial Repetitive Nerve Stimulation Test Predicts Conversion of Ocular Myasthenia Gravis to Generalized Myasthenia Gravis
por: Kim, Ki Hoon, et al.
Publicado: (2021) -
Efficacy and Safety of Tacrolimus in Myasthenia Gravis: A Systematic Review and Meta-analysis
por: Zhang, Zuojie, et al.
Publicado: (2017) -
Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis
por: Muppidi, Srikanth, et al.
Publicado: (2019) -
Clinical Significance of Repetitive Compound Muscle Action Potentials in Patients with Myasthenia Gravis: A Predictor for Cholinergic Side Effects of Acetylcholinesterase Inhibitors
por: Lee, Hyo Eun, et al.
Publicado: (2016)